All opinions contained within pieces presented on this page are published at the discretion of the author and/or publisher. The DETOUR System is an investigational device limited by United States law to investigational use. The DETOUR System is not available for sale.
PQ Bypass: PQ Bypass Reports Positive 12-Month Results for Entirely New Procedure to Treat Extremely Long SFA Lesions in Patients with PAD
PQ Bypass: PQ Bypass Announces First Patient Treated in Landmark DETOUR II Trial Evaluating New Treatment Approach for Clogged Leg Arteries
PQ Bypass: PQ Bypass Reports Positive Results for the Novel DETOUR System in Patients With Tough to Treat Long Blockages in the Femoropopliteal Artery
Frost & Sullivan: PQ Bypass- Recipient of Frost & Sullivan's 2017 European Peripheral Artery Disease Interventions Technology Innovation Award
Frost & Sullivan: PQ Bypass Earns Frost & Sullivan's European Technology Innovation Award for Its Proprietary DETOUR System for Percutaneous Bypass
Cision: Sanarus Technologies Appoints Senior Medtech Executive Heather Simonsen to Board of Directors
Endovascular Today: Early Findings Presented for PQ Bypass’ Endovascular Femoropopliteal Artery Bypass Procedure